AMT-253

AMT-253 · Multitude Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMT-253, covering 2025-08-14 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: AMT-253 in Patients With Advanced Solid Tumours [Phase 1, Phase 2]